| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Canadian Journal of Anesthesia, Vol 40, 1016-1021, Copyright © 1993 by Canadian Anesthesiologists' Society
ARTICLES |
T Kawamura, R Wakusawa, K Okada and S Inada
Department of Anesthesiology, Iwate Medical University, Morioka, Japan.
Myocardial ischaemia is one of the major causes of low output syndrome during open heart surgery. Injury associated with ischaemia and reperfusion has been considered to result, in part, from the action of neutrophils, the interaction of neutrophils with vascular endothelial cells, and the effects of cytokines which are mediators that induce and modify reactions between these substances. We investigated cell injury in relation to the concentrations of interleukins 6 and 8 (IL-6 and IL-8), which have recently received attention as neutrophil activators. Neutrophil counts, granulocyte elastase (GEL), IL-6, IL-8, tumour necrosis factor-alpha (TNF-alpha), CK, and CK-MB concentrations were determined serially in 11 patients undergoing open heart surgery with cardiopulmonary bypass (CPB). Neutrophil counts (mean +/- SD 2717 +/- 2421 microliters-1 preoperatively) peaked 60 min after declamping the aorta at 7432 +/- 4357 microliters-1 (P < 0.01) and remained elevated 7136 +/- 5194 microliters-1 at 180 min (P < 0.01). Plasma GEL level (168 +/- 71 micrograms.L-1 preoperatively) peaked at 1134 +/- 453 micrograms.L-1 120 min after declamping of the aorta (P < 0.01) and remained elevated, 1062 +/- 467 micrograms.L-1, after 180 min (P < 0.01). Serum IL-6 level (118 +/- 59 pg.ml-1 preoperatively) peaked at 436 +/- 143 pg.ml-1 60 min after declamping of the aorta (P < 0.01) and remained elevated, 332 +/- 109 pg.ml-1, after 180 min. Serum IL-8 level (37 +/- 44 pg.ml-1 preoperatively) peaked at 169 +/- 86 pg.ml-1 at 60 min after declamping of the aorta (P < 0.001) and remained elevated at 113 +/- 78 pg.ml-1 180 min after declamping of the aorta.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
Y. Orr, D. P. Wilson, J. M. Taylor, P. G. Bannon, C. Geczy, M. P. Davenport, and L. Kritharides A kinetic model of bone marrow neutrophil production that characterizes late phenotypic maturation Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1707 - R1716. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Jessen Pro: Heparin-Coated Circuits Should be Used for Cardiopulmonary Bypass Anesth. Analg., December 1, 2006; 103(6): 1365 - 1369. [Full Text] [PDF] |
||||
![]() |
T. Kotani, Y. Kotake, H. Morisaki, J. Takeda, H. Shimizu, T. Ueda, and A. Ishizaka Activation of a Neutrophil-Derived Inflammatory Response in the Airways During Cardiopulmonary Bypass Anesth. Analg., December 1, 2006; 103(6): 1394 - 1399. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Hsing, M.-Y. Hsieh, W.-Y. Chen, E. Cheung So, B.-C. Cheng, and M.-S. Chang Induction of Interleukin-19 and Interleukin-22 After Cardiac Surgery With Cardiopulmonary Bypass Ann. Thorac. Surg., June 1, 2006; 81(6): 2196 - 2201. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Cagli, M. M. Ulas, K. Ozisik, A. Kale, V. Bakuy, M. Emir, M. Balci, M. Topbas, E. Sener, and O. Tasdemir The intraoperative effect of pentoxifylline on the inflammatory process and leukocytes in cardiac surgery patients undergoing cardiopulmonary bypass Perfusion, January 1, 2005; 20(1): 45 - 51. [Abstract] [PDF] |
||||
![]() |
Y. Hayashi, Y. Sawa, M. Nishimura, N. Fukuyama, H. Ichikawa, S. Ohtake, H. Nakazawa, and H. Matsuda Peroxynitrite, a product between nitric oxide and superoxide anion, plays a cytotoxic role in the development of post-bypass systemic inflammatory response Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 276 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Clark, L. M. Alleva, A. C. Mills, and W. B. Cowden Pathogenesis of Malaria and Clinically Similar Conditions Clin. Microbiol. Rev., July 1, 2004; 17(3): 509 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Lappegard, M. Fung, G. Bergseth, J. Riesenfeld, and T. E. Mollnes Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition Ann. Thorac. Surg., July 1, 2004; 78(1): 38 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gilles, S. Zahler, U. Welsch, C. P Sommerhoff, and B. F Becker Release of TNF-{alpha} during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers Cardiovasc Res, December 1, 2003; 60(3): 608 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Greilich, C. F. Brouse, C. W. Whitten, L. Chi, J. M. DiMaio, and M. E. Jessen Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of {epsilon}-aminocaproic acid and aprotinin J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1498 - 1503. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Harmon, E. Coleman, C. Marshall, W. Lan, and G. Shorten The Effect of Clomethiazole on Plasma Concentrations of Interleukin-6, -8, -1{beta}, Tumor Necrosis Factor-{alpha}, and Neutrophil Adhesion Molecule Expression During Experimental Extracorporeal Circulation Anesth. Analg., July 1, 2003; 97(1): 13 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Mayers, T. Hurst, A. Radomski, D. Johnson, S. Fricker, G. Bridger, B. Cameron, M. Darkes, and M. W. Radomski Increased matrix metalloproteinase activity after canine cardiopulmonary bypass is suppressed by a nitric oxide scavenger J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 661 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sason-Ton, R. Ben Abraham, D. Lotan, O. Dagan, T. Prince, Z. Barzilay, and G. Paret Tumor necrosis factor and clinical and metabolic courses after cardiac surgery in children J. Thorac. Cardiovasc. Surg., November 1, 2002; 124(5): 991 - 998. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Borgermann, I. Friedrich, S. Flohe, J. Spillner, M. Majetschak, O. Kuss, A. Sablotzki, T. Feldt, J. C. Reidemeister, and F. U. Schade Tumor necrosis factor-{alpha} production in whole blood after cardiopulmonary bypass: Downregulation caused by circulating cytokine-inhibitory activities J. Thorac. Cardiovasc. Surg., September 1, 2002; 124(3): 608 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Stangl, G. Baumann, K. Stangl, and S. B Felix Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion Cardiovasc Res, January 1, 2002; 53(1): 12 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Chishti, J. H. Dark, P. Kesteven, H. Powell, C. Snowden, B. K. Shenton, J. A. Kirby, and S. V. Baudouin Expression of chemokine receptors CXCR1 and CXCR2 during cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., December 1, 2001; 122(6): 1162 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Hennein Inflammation After Cardiopulmonary Bypass: Therapy for the Postpump Syndrome Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 236 - 255. [Abstract] [PDF] |
||||
![]() |
M. Fung, P. G. Loubser, A. Undar, M. Mueller, C. Sun, W. N. Sun, W. K. Vaughn, and C. D. Fraser Jr Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits J. Thorac. Cardiovasc. Surg., July 1, 2001; 122(1): 113 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R Glogowski, A. H Stammers, K. S Niimi, K. D Tremain, M. L Muhle, and C. C Trowbridge The effect of priming techniques of ultrafiltrators on blood rheology: an in vitro evaluation Perfusion, May 1, 2001; 16(3): 221 - 228. [Abstract] [PDF] |
||||
![]() |
U. Kiziltepe, A. Uysalel, T. Corapcioglu, K. Dalva, H. Akan, and H. Akalin Effects of combined conventional and modified ultrafiltration in adult patients Ann. Thorac. Surg., February 1, 2001; 71(2): 684 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lotan, D. Zilberman, O. Dagan, N. Keller, R. Ben-Abraham, A. A. Weinbroum, R. Harel, Z. Barzilay, and G. Paret {beta}-Chemokine secretion patterns in relation to clinical course and outcome in children after cardiopulmonary bypass: continuing the search to abrogate systemic inflammatory response Ann. Thorac. Surg., January 1, 2001; 71(1): 233 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Dreyer, S. C. Phillips, M. L. Lindsey, P. Jackson, N. E. Bowles, L. H. Michael, and M. L. Entman Interleukin 6 induction in the canine myocardium after cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., August 1, 2000; 120(2): 256 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kotani, H. Hashimoto, D. I. Sessler, M. Muraoka, J.-S. Wang, M. F. O'Connor, and A. Matsuki Neutrophil Number and Interleukin-8 and Elastase Concentrations in Bronchoalveolar Lavage Fluid Correlate with Decreased Arterial Oxygenation After Cardiopulmonary Bypass Anesth. Analg., May 1, 2000; 90(5): 1046 - 1051. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Matata, A. W. Sosnowski, and M. Galinanes Off-pump bypass graft operation significantly reduces oxidative stress and inflammation Ann. Thorac. Surg., March 1, 2000; 69(3): 785 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ozawa, K. Yoshihara, N. Koyama, Y. Watanabe, N. Shiono, and Y. Takanashi Clinical efficacy of heparin-bonded bypass circuits related to cytokine responses in children Ann. Thorac. Surg., February 1, 2000; 69(2): 584 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamazaki, H. Ooshima, A. Usui, T. Watanabe, and K. Yasuura Protective effects of ONO-5046{middle dot}Na, a specific neutrophil elastase inhibitor, on postperfusion lung injury Ann. Thorac. Surg., December 1, 1999; 68(6): 2141 - 2146. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nandate, A. Vuylsteke, A. E. Crosbie, S. Messahel, A. Oduro-Dominah, and D. K. Menon Cerebrovascular Cytokine Responses During Coronary Artery Bypass Surgery: Specific Production of Interleukin-8 and Its Attenuation by Hypothermic Cardiopulmonary Bypass Anesth. Analg., October 1, 1999; 89(4): 823 - 823. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ashraf, K. Bhattacharya, Y. Tian, and K. Watterson Cytokine and S100B levels in paediatric patients undergoing corrective cardiac surgery with or without total circulatory arrest Eur. J. Cardiothorac. Surg., July 1, 1999; 16(1): 32 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Cook Changing Temperature Management for Cardiopulmonary Bypass Anesth. Analg., June 1, 1999; 88(6): 1254 - 1254. [Full Text] [PDF] |
||||
![]() |
M. Yilmaz, S. Ener, H. Akalin, K. Sagdic, O A. Serdar, and M. Cengiz Effect of low-dose methyl prednisolone on serum cytokine levels following extracorporeal circulation Perfusion, May 1, 1999; 14(3): 201 - 206. [Abstract] [PDF] |
||||
![]() |
I. Mayers, E. Salas, T. Hurst, D. Johnson, and M. W. Radomski INCREASED NITRIC OXIDE SYNTHASE ACTIVITY AFTER CANINE CARDIOPULMONARY BYPASS IS SUPPRESSED BY S-NITROSOGLUTATHIONE J. Thorac. Cardiovasc. Surg., May 1, 1999; 117(5): 1009 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Asimakopoulos and K. M. Taylor Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules Ann. Thorac. Surg., December 1, 1998; 66(6): 2135 - 2144. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wang, H. M. Huang, De Ming Zhu, H. Chen, Z. K. Su, and W. X. Ding Modified ultrafiltration in paediatric cardiopulmonary bypass Perfusion, September 1, 1998; 13(5): 304 - 310. [Abstract] [PDF] |
||||
![]() |
C. Marie, J. Muret, C. Fitting, M.-R. Losser, D. Payen, and J.-M. Cavaillon Reduced Ex Vivo Interleukin-8 Production by Neutrophils in Septic and Nonseptic Systemic Inflammatory Response Syndrome Blood, May 1, 1998; 91(9): 3439 - 3446. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Steingrub Novel Insights Into the Pathogenesis and Therapy of Circulatory Shock Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1998; 2(1): 31 - 45. [Abstract] [PDF] |
||||
![]() |
J. Boldt, B. Kumle, M. Papsdorf, and G. Hempelmann Are Circulating Adhesion Molecules Specifically Changed in Cardiac Surgical Patients? Ann. Thorac. Surg., March 1, 1998; 65(3): 608 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ashraf, J. Butler, Y. Tian, D. Cowan, S. Lintin, N. R. Saunders, K. G. Watterson, and P. G. Martin Inflammatory Mediators in Adults Undergoing Cardiopulmonary Bypass: Comparison of Centrifugal and Roller Pumps Ann. Thorac. Surg., February 1, 1998; 65(2): 480 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ashraf, Y. Tian, D. Cowan, A. Entress, P. G. Martin, and K. G. Watterson Release of Proinflammatory Cytokines During Pediatric Cardiopulmonary Bypass: Heparin-Bonded Versus Nonbonded Oxygenators Ann. Thorac. Surg., December 1, 1997; 64(6): 1790 - 1794. [Abstract] [Full Text] |
||||
![]() |
T. Ohata, Y. Sawa, K. Kadoba, T. Masai, H. Ichikawa, and H. Matsuda Effect of Cardiopulmonary Bypass Under Tepid Temperature on Inflammatory Reactions Ann. Thorac. Surg., July 1, 1997; 64(1): 124 - 128. [Abstract] [Full Text] |
||||
![]() |
S. Wan, J.-L. LeClerc, and J.-L. Vincent Cytokine Responses to Cardiopulmonary Bypass: Lessons Learned From Cardiac Transplantation Ann. Thorac. Surg., January 1, 1997; 63(1): 269 - 276. [Abstract] [Full Text] |
||||
![]() |
J. M Courtney, B. M Matata, H. Q Yin, A. Esposito, A. Mahiout, D. P Taggart, and G. Lowe The influence of biomaterials on inflammatory responses to cardiopulmonary bypass Perfusion, May 1, 1996; 11(3): 220 - 228. [PDF] |
||||
![]() |
M.-C. Seghaye, J. Duchateau, J. Bruniaux, S. Demontoux, C. Bosson, A. Serraf, G. Lecronier, E. Mokhfi, and C. Planche INTERLEUKIN-10 RELEASE RELATED TO CARDIOPULMONARY BYPASS IN INFANTS UNDERGOING CARDIAC OPERATIONS J. Thorac. Cardiovasc. Surg., March 1, 1996; 111(3): 545 - 553. [Abstract] [Full Text] |
||||
![]() |
M.-J. Wang, I.-S. Chiu, C.-M. Hsu, C.-M. Wang, P.-L. Lin, C.-I Chang, C.-H. Huang, and S.-H. Chu Efficacy of Ultrafiltration in Removing Inflammatory Mediators During Pediatric Cardiac Operations Ann. Thorac. Surg., February 1, 1996; 61(2): 651 - 656. [Abstract] [Full Text] |
||||
![]() |
S. Wan, J.-M. DeSmet, M. Antoine, M. Goldman, J.-L. Vincent, and J.-L. LeClerc Steroid Administration in Heart and Heart-Lung Transplantation: Is the Timing Adequate? Ann. Thorac. Surg., February 1, 1996; 61(2): 674 - 678. [Abstract] [Full Text] |
||||
![]() |
S. Wan, A. Marchant, J.-M. DeSmet, M. Antoine, H. Zhang, J.-L. Vachiery, M. Goldman, J.-L. Vincent, and J.-L. LeClerc HUMAN CYTOKINE RESPONSES TO CARDIAC TRANSPLANTATION AND CORONARY ARTERY BYPASS GRAFTING J. Thorac. Cardiovasc. Surg., February 1, 1996; 111(2): 469 - 477. [Abstract] [Full Text] |
||||
![]() |
Y. Sawa, Y. Shimazaki, K. Kadoba, T. Masai, H. Fukuda, T. Ohata, K. Taniguchi, and H. Matsuda ATTENUATION OF CARDIOPULMONARY BYPASS-DERIVED INFLAMMATORY REACTIONS REDUCES MYOCARDIAL REPERFUSION INJURY IN CARDIAC OPERATIONS J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 29 - 35. [Abstract] [Full Text] |
||||
![]() |
P. W. Weerwind, J. G. Maessen, L. J. H. van Tits, R. K. Stad, E. J. Fransen, D. S. de Jong, and O. C. K. M. Penn INFLUENCE OF DURAFLO II HEPARIN-TREATED EXTRACORPOREAL CIRCUITS ON THE SYSTEMIC INFLAMMATORY RESPONSE IN PATIENTS HAVING CORONARY BYPASS J. Thorac. Cardiovasc. Surg., December 1, 1995; 110(6): 1633 - 1641. [Abstract] [Full Text] |
||||
![]() |
S. A. Burns, J. W. Newburger, M. Xiao, J. E. Mayer Jr, A. Z. Walsh BSN, and E. J. Neufeld Induction of Interleukin-8 Messenger RNA in Heart and Skeletal Muscle During Pediatric Cardiopulmonary Bypass Circulation, November 1, 1995; 92(9): 315 - 321. [Abstract] [Full Text] |
||||
![]() |
K. H.T. Teoh, C. A. Bradley, J. Gauldie, and H. Burrows Steroid Inhibition of Cytokine-Mediated Vasodilation After Warm Heart Surgery Circulation, November 1, 1995; 92(9): 347 - 353. [Abstract] [Full Text] |
||||
![]() |
B. M. Steinberg, E. A. Grossi, D. S. Schwartz, D. E. McLoughlin, M. Aguinaga, C. Bizekis, J. Greenwald, A. Flisser, F. C. Spencer, A. C. Galloway, et al. Heparin Bonding of Bypass Circuits Reduces Cytokine Release During Cardiopulmonary Bypass Ann. Thorac. Surg., September 1, 1995; 60(3): 525 - 529. [Abstract] [Full Text] |
||||
![]() |
R. M. Engelman, J. A. Rousou, J. E. Flack III, D. W. Deaton, R. Kalfin, and D. K. Das Influence of Steroids on Complement and Cytokine Generation After Cardiopulmonary Bypass Ann. Thorac. Surg., September 1, 1995; 60(3): 801 - 804. [Abstract] [Full Text] |
||||
![]() |
B. Frering, I. Philip, M. Dehoux, C. Rolland, J. M. Langlois, and J. M. Desmonts Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., October 1, 1994; 108(4): 636 - 641. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |